Nous-209 neoantigen vaccine for cancer prevention in Lynch syndrome carriers: a phase 1b/2 trial. (nature.com)

Authors: D'Alise AM … Vilar E Journal: Nature Medicine Published: 2026-03-01 DOI: https://doi.org/10.1038/s41591-025-04182-9